Inhibition of such alternative activation of ERK, JNK and p38 in aged mice increased both CD4+ T-cell and B-cell response to influenza vaccination, suggesting that MAPKs may be targeted to improve influenza vaccine efficacy in the elderly. Here, CD4 is linked to influenza.